Lifevantage Income After Taxes 2010-2024 | LFVN

Lifevantage income after taxes from 2010 to 2024. Income after taxes can be defined as earnings or losses after income tax expense but before minority interest, extraordinary items, discontinued operations, preferred dividends and accounting changes have been accounted for.
Lifevantage Annual Income After Taxes
(Millions of US $)
2024 $3
2023 $3
2022 $3
2021 $13
2020 $12
2019 $7
2018 $6
2017 $2
2016 $6
2015 $7
2014 $11
2013 $8
2012 $12
2011 $-51
2010 $-11
2009 $-0
Lifevantage Quarterly Income After Taxes
(Millions of US $)
2024-09-30 $2
2024-06-30 $1
2024-03-31 $2
2023-12-31 $-1
2023-09-30 $1
2023-06-30 $2
2023-03-31 $1
2022-12-31 $-1
2022-09-30 $1
2022-06-30 $-1
2022-03-31 $1
2021-12-31 $0
2021-09-30 $3
2021-06-30 $5
2021-03-31 $2
2020-12-31 $4
2020-09-30 $2
2020-06-30 $4
2020-03-31 $2
2019-12-31 $4
2019-09-30 $2
2019-06-30 $4
2019-03-31 $2
2018-12-31 $1
2018-09-30 $1
2018-06-30 $3
2018-03-31 $2
2017-12-31 $0
2017-09-30 $1
2017-06-30 $0
2017-03-31 $0
2016-12-31 $0
2016-09-30 $1
2016-06-30 $2
2016-03-31 $1
2015-12-31 $2
2015-09-30 $1
2015-06-30 $0
2015-03-31 $1
2014-12-31 $1
2014-09-30 $5
2014-06-30 $2
2014-03-31 $2
2013-12-31 $3
2013-09-30 $3
2013-06-30 $-0
2013-03-31 $3
2012-12-31 $0
2012-09-30 $4
2012-06-30 $5
2012-03-31 $-5
2011-12-31 $9
2011-09-30 $4
2011-06-30 $-47
2011-03-31 $-10
2010-12-31 $5
2010-09-30 $1
2010-06-30 $-5
2010-03-31 $-8
2009-12-31 $-1
2009-09-30 $3
2009-06-30 $-5
2009-03-31 $-3
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $0.176B $0.200B
Lifevantage Corporation is a health and nutrition company. The company is the maker of Protandim(R), the Nrf2 Synergizer(R) patented dietary supplement, the TrueScience(TM) Anti-Aging Skin Care Regimen, Canine Health and the AXIO(TM) energy product line. Lifevantage Corporation is headquartered in Salt Lake City, Utah.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $78.143B 21.32
Becton Dickinson (BDX) United States $67.812B 17.83
Cardinal Health (CAH) United States $29.438B 15.96
West Pharmaceutical Services (WST) United States $23.723B 48.46
Cooper (COO) United States $20.623B 29.35
Labcorp (LH) United States $20.401B 16.92
Align Technology (ALGN) United States $16.815B 32.18
Henry Schein (HSIC) United States $8.514B 16.22
Merit Medical Systems (MMSI) United States $6.067B 30.98
DENTSPLY SIRONA (XRAY) United States $3.508B 9.54
CONMED (CNMD) United States $2.312B 19.29
Patterson (PDCO) United States $1.855B 9.79
STAAR Surgical (STAA) United States $1.499B 55.31
Pro-Dex (PDEX) United States $0.154B 30.74